Detecting Sepsis in Patients With Severe Subarachnoideal Hemorrhage
1 other identifier
observational
58
1 country
1
Brief Summary
The study aims to evaluate the suitability of the SOFA score implemented by the Sepsis 3 guideline to detect sepsis in patients suffering from subrarachnoid hemorrhage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2022
CompletedFirst Submitted
Initial submission to the registry
February 9, 2022
CompletedFirst Posted
Study publicly available on registry
February 18, 2022
CompletedMarch 29, 2022
March 1, 2022
1 year
February 9, 2022
March 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Sepsis SOFA positive
Sepsis correctly detected by SOFA score (Sepsis-related organ failure assessment score, 0-24 points)
up to 2 months
Sepsis SOFA negative
Sepsis not detected by SOFA score (Sepsis-related organ failure assessment score, 0-24 points)
up to 2 months
Interventions
The aim of the study was to observe whether the treating physicians were able to detect sepsis by strictly applying the recommended SOFA score.
Eligibility Criteria
Patients with severe subarachnoid hemorrhage requiring intensive care.
You may qualify if:
- Critically ill patients suffering from moderate to severe subarachnoid hemorrhage (WFNS \>2).
You may not qualify if:
- children under the age of 18 years Patients with minor subarachnoid hemorrhage \< WFNS stage 2.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Frankfurt
Niederrad, Hesse, 60590, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 9, 2022
First Posted
February 18, 2022
Study Start
June 1, 2017
Primary Completion
June 1, 2018
Study Completion
February 1, 2022
Last Updated
March 29, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share
The dataset will be published in an international journal. The data will be available upon reasonable request from the corresponding author